0001493152-24-007491.txt : 20240221
0001493152-24-007491.hdr.sgml : 20240221
20240221214631
ACCESSION NUMBER: 0001493152-24-007491
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240216
FILED AS OF DATE: 20240221
DATE AS OF CHANGE: 20240221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hariri Robert J
CENTRAL INDEX KEY: 0001398815
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38914
FILM NUMBER: 24662093
MAIL ADDRESS:
STREET 1: 341 MENDHAM ROAD
CITY: BERNARDSVILLE
STATE: NJ
ZIP: 07924
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celularity Inc
CENTRAL INDEX KEY: 0001752828
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 831702591
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 170 PARK AVE
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
BUSINESS PHONE: (908) 768-2170
MAIL ADDRESS:
STREET 1: 170 PARK AVE
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
FORMER COMPANY:
FORMER CONFORMED NAME: GX Acquisition Corp.
DATE OF NAME CHANGE: 20180912
4
1
ownership.xml
X0508
4
2024-02-16
0
0001752828
Celularity Inc
CELU
0001398815
Hariri Robert J
C/O CELULARITY INC.
170 PARK AVENUE
FLORHAM PARK
NJ
07932
1
1
0
0
Chief Executive Officer
0
Stock Option Grant (Right to Buy)
0.4340
2024-02-16
4
A
0
2937788
0.00
A
2034-02-15
Class A Common Stock
2937788
2937788
D
The option was granted pursuant to the Issuer's 2021 Equity Incentive Plan. The shares underlying such option will vest in equal quarterly installments during 2024 such that 25% of the option will vest on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024, subject to the Reporting Person's continuous service with the Issuer through each such date.
/s/ Kyle Fletcher, Attorney-in-Fact
2024-02-21